New candidates for true antisense
- 1 January 2001
- journal article
- editorial
- Published by Springer Nature in Nature Biotechnology
- Vol. 19 (1) , 17-18
- https://doi.org/10.1038/83451
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivoNature Biotechnology, 2001
- Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patientsProceedings of the National Academy of Sciences, 2000
- Potent and nontoxic antisense oligonucleotides containing locked nucleic acidsProceedings of the National Academy of Sciences, 2000
- Oligonucleotide N3′→P5′ phosphoramidates as potential therapeutic agentsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
- Hybrids of RNA and Arabinonucleic Acids (ANA and 2‘F-ANA) Are Substrates of Ribonuclease H J. Am. Chem. Soc. 1998, 120, 12976−12977Journal of the American Chemical Society, 1998
- 2′-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial CellsJournal of Biological Chemistry, 1997
- Antileukemia effect of c- myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivoProceedings of the National Academy of Sciences, 1997
- Does antisense exist?Nature Medicine, 1995
- RNase H is responsible for the non-specific inhibition ofin vitrotranslation by 2′-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomersNucleic Acids Research, 1995